Novel Oral GLP-1 Agent Cuts A1c, Weight in Early Diabetes

Watchdoq June 21, 2025
(MedPage Today) -- CHICAGO -- An investigational, oral small-molecule GLP-1 receptor agonist improved glycated hemoglobin levels in adults with early-stage type 2 diabetes, a phase III randomized trial found.
Among 559 participants in ACHIEVE...

Read Full Article